Search
for
Sort by
Research 961–990 of 1000+
- Finasteride in the treatment of men with frontal male pattern hair loss
- A New Look at the 5?-Reductase Inhibitor Finasteride
- Hormonal Organization of Sex Differences in Play Fighting and Spatial Behavior
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- Prolactin Signaling Influences the Timing Mechanism of the Hair Follicle: Analysis of Hair Growth Cycles in Prolactin Receptor Knockout Mice*
- The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride
- Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
- Growth hormone substitution in adult growth hormone‐deficient men augments androgen effects on the skin
- Nipple Differentiation in Fetal Male Rats Treated with an Inhibitor of the Enzyme 5<i>α</i>-Reductase: Definition of a Selective Role for Dihydrotestosterone*
- Androgen Regulation of the Human Hair Follicle: The Type I Hair Keratin hHa7 Is a Direct Target Gene in Trichocytes
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate
- Pubertal Development
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Chapter 7 Reproductive Dysfunction in Women with Epilepsy
- Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years
- Guidelines on the use of finasteride in androgenetic alopecia
- Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Altered brain and pituitary androgen metabolism by prenatal, perinatal or pre- and postnatal finasteride, flutamide or dihydrotestosterone treatment in juvenile male rats
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
- Medical management of male pattern hair loss
- Alterations of gut microbiota composition in post-finasteride patients: a pilot study